# PECS Block: Plasma Bupivacaine Level

> **NCT03059498** · EARLY_PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Nerve Blocks

## Interventions

- **PROCEDURE:** Unilateral PECS I and II block
- **PROCEDURE:** Bilateral PECS I and II block
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03059498
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-06
- **Primary completion:** 2017-11-15
- **Final completion:** 2017-11-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059498, "PECS Block: Plasma Bupivacaine Level". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03059498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*